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Many times; the combination of antibiotics is proved to be a better alternative in 
therapy; especially when the associated antibiotics are synergic. In this study; two bactericidal 
antibiotics – enrofloxacin and ceftiofur – were clinically tested in young sheep diagnosed with 
salmonellosis; by interpreting the value of fibrinogen; an acute phase reactant; before the 
therapy; and also in day 1;3; and 7 of treatment; in the groups treated both with a combination 
of antibiotics and also with an antibiotic alone. 
 The values of the fibrinogen were two times higher; at the beginning of the therapy; in 
diseased sheep than the values of the control group; after a day of treatment; the fibrinogen 
increased in ENR group; meanwhile in ENR+EFT group started to decrease; in the day 3 of 
therapy; the fibrinogen increased more in ENR group; but for ENR+EFT group it was 
registered the grew less and less in comparison with day 1;  the day 7 present the fibrinogen in 
ENR group in a pronounced  decreasing than the day 3 ; the high value of the fibrinogen in 
ENR group in comparison with the decreasing of the fibrinogen values in ENR+EFT group 
determined a statistically distinct significant difference between the treated groups.  
Analyzing these data; it can be considered that enrofloxacin combined with ceftiofur 
was more efficient; starting with day 3; in comparison with enrofloxacin; that had better 
results after 7 days of treatment. 
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